Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment

Autor: Tekpli, Xavier, Lien, Tonje Gulbrandsen, Røssevold, Andreas Hagen, Nebdal, Daniel J.H., Borgen, Elin, Ohnstad, Hege Oma, Kyte, Jon A, Vallon-Christersson, Johan, Fongaard, Marie, Due, Eldri Undlien, Svartdal, Lisa Gregusson, Sveli, My Anh Tu, Garred, Øystein, Frigessi Di Rattalma, Arnoldo, Sahlberg, Kristine Kleivi, Sørlie, Therese, Russnes, Hege Elisabeth Giercksky, Naume, Bjørn, Kristensen, Vessela N.

Publikováno v: Tekpli, Xavier Lien, Tonje Gulbrandsen Røssevold, Andreas Hagen Nebdal, Daniel J.H. Borgen, Elin Ohnstad, Hege Oma Kyte, Jon A Vallon-Christersson, Johan Fongaard, Marie Due, Eldri Undlien Svartdal, Lisa Gregusson Sveli, My Anh Tu Garred, Øystein Frigessi Di Rattalma, Arnoldo Sahlberg, Kristine Kleivi Sørlie, Therese Russnes, Hege Elisabeth Giercksky Naume, Bjørn Kristensen, Vessela N. . An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment. Nature Communications. 2019, 10:5499, 1-14
Nature Communications

Externí odkaz: http://hdl.handle.net/10852/76533
https://www.duo.uio.no/bitstream/handle/10852/76533/1/s41467-019-13329-5.pdf

Additional file 2: Table S1. of Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up

Autor: Ohnstad, Hege, Borgen, Elin, Falk, Ragnhild, Lien, Tonje, Aaserud, Marit, Sveli, My, Kyte, Jon, Kristensen, Vessela, Geitvik, Gry, Schlichting, Ellen, Wist, Erik, SøRlie, Therese, Russnes, Hege, BjøRn Naume

Multivariate analysis of DDFS and BCSS for all patients, including PAM50 intrinsic subtypes. (DOC 49 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ccb1e424ee7caaabe2ebce0a10a85768

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment.

Autor: Tekpli X; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Lien T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Røssevold AH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Nebdal D; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Borgen E; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Ohnstad HO; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Kyte JA; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Vallon-Christersson J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Scheelegatan 2, Medicon Village, 22185, Lund, Sweden., Fongaard M; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Due EU; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Svartdal LG; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Sveli MAT; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Garred Ø; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Frigessi A; Department of Biostatistics, Oslo Centre for Biostatistics and Epidemiology, University of Oslo and Research Support Services, Oslo University Hospital, Oslo, Norway., Sahlberg KK; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Research, Vestre Viken Hospital Trust, Drammen, Norway., Sørlie T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Biomarkers CCBIO, Bergen, Norway., Russnes HG; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Naume B; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Kristensen VN; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Vessela.N.Kristensen@rr-research.no.; Centre for Cancer Biomarkers CCBIO, Bergen, Norway. Vessela.N.Kristensen@rr-research.no.; Department of Clinical Molecular Biology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway. Vessela.N.Kristensen@rr-research.no.

Publikováno v: Nature communications [Nat Commun] 2019 Dec 03; Vol. 10 (1), pp. 5499. Date of Electronic Publication: 2019 Dec 03.